Engineers in Gaza have no time for bluster and fantasy about the place they know as home. They must deal every day with the ...

LOS ANGELES -- For patients with large vessel occlusion (LVO) strokes, researchers found ways to make adjunctive ...

During the 1950s and 1960s, I remember the government-conducted Civil Defense drills in my school. We were told to climb under our school desks, duck down and cover our heads. We might have survived a ...

First-person shooters are a tough genre to get into if someone has never played them before. Some get so hard that they are ...

Tectonic Therapeutic has done well to advance its Fc-fusion protein candidate TX45 into a phase 2 study targeting patients ...

Bicycle Therapeutics' BT8009 offers strong safety and efficacy. Find out why BCYC stock could be a buy, despite recent volatility and awaiting mid-2025 data.

Volatility can signal investor fear but also offer an opportunity to clear minded buyers. Among professional portfolio managers, views vary on what action to take to protect their clients’ funds. Some ...

The stock is trading at 1.0150, up 0.6573, gaining 183.7573% on volume of over 422 Million shares, with a day's high of $1.11. The stock announced breaking news on its Monoclonal Antibody designed to ...

Strattera is prescribed to treat ADHD. Learn more about how long the drug takes to kick in and how long it lasts.

This important study shows that the activity of hypothalamic hypocretin/orexin neurons (HONs) correlates with body movement over multiple behaviors. Sophisticated techniques and analyses showcase this ...

Guest blog by Luisa Doughty, Mission Manager and Sarah Cheesbrough, Misson Manager at the Satellite Applications Catapult.

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS ...